Mayzent and Calcinosis - a phase IV clinical study of FDA data
We study 10,553 people who take Mayzent or have Calcinosis. No report of Calcinosis is found in people who take Mayzent.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Mayzent?
Mayzent has active ingredients of siponimod fumaric acid. eHealthMe is studying from 7,240 Mayzent users for its effectiveness, alternative drugs and more.
What is Calcinosis?
Calcinosis (calcium deposits in any soft tissue) is found to be associated with 1,427 drugs and 809 conditions by eHealthMe.
Do you take Mayzent and have Calcinosis?Check whether Calcinosis is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Calcinosis and when was it recovered:
Expand to all the drugs that have ingredients of siponimod fumaric acid:
Alternative drugs to, pros and cons of Mayzent:
- Mayzent (7,240 reports)
Calcinosis treatments and more:
- Calcinosis (3,313 reports)
COVID vaccines that are related to Calcinosis:
- Calcinosis in Moderna COVID Vaccine
- Calcinosis in Pfizer BioNTech Covid Vaccine
- Calcinosis in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Calcinosis:
All the conditions that are associated with Calcinosis:
How the study uses the data?
The study uses data from the FDA. It is based on siponimod fumaric acid (the active ingredients of Mayzent) and Mayzent (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Somavert and Temperature Intolerance - a second ago
- Propecia and Procedural Complication - 5 seconds ago
- Oral Contraception and Jaundice - Yellow Skin - 6 seconds ago
- Atacand and Pulmonary Oedema - 7 seconds ago
- Monodox and Venclexta drug interaction - 10 seconds ago
- Tacrolimus and Samsca drug interaction - 16 seconds ago
- Cotrim and Atarax drug interaction - 17 seconds ago
- Vagifem and Eye Movement Disorder - 20 seconds ago
- Cenestin and Vasotec drug interaction - 28 seconds ago
- Clopidogrel and Visual Impairment - 30 seconds ago